tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OPT Stock Latest News

Opthea Announces Upcoming Presentations at the Retina World Congress 2024
Press ReleasesOpthea Announces Upcoming Presentations at the Retina World Congress 2024
2d ago
OPT
Opthea to Present at the OIS Retina Innovation Summit at ARVO
PremiumPress Releases
Opthea to Present at the OIS Retina Innovation Summit at ARVO
8d ago
OPT
Opthea Appoints John Han, PharmD, as VP Medical Affairs
PremiumPress Releases
Opthea Appoints John Han, PharmD, as VP Medical Affairs
25d ago
OPT
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference 
PremiumPress Releases
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference 
29d ago
OPT
Opthea Appoints Sujal Shah to the Board of Directors
PremiumPress Releases
Opthea Appoints Sujal Shah to the Board of Directors
30d ago
OPT
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
PremiumPress ReleasesOpthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
2M ago
OPT
Opthea to Participate in the Leerink Partners Global Biopharma Conference
PremiumPress Releases
Opthea to Participate in the Leerink Partners Global Biopharma Conference
2M ago
OPT
Opthea Reports Half-Year Financial Results and Business Updates
PremiumPress Releases
Opthea Reports Half-Year Financial Results and Business Updates
2M ago
OPT
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
PremiumPress Releases
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
2M ago
OPT
Opthea completes enrollment in COAST Phase 3 trial of sozinibercept
PremiumThe Fly
Opthea completes enrollment in COAST Phase 3 trial of sozinibercept
3M ago
OPT
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
PremiumPress Releases
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
3M ago
OPT
Opthea Strengthens Team with Key Clinical and Regulatory Hires
PremiumPress Releases
Opthea Strengthens Team with Key Clinical and Regulatory Hires
3M ago
OPT
Opthea to receive remaining $35M under Development Funding Agreement
PremiumThe FlyOpthea to receive remaining $35M under Development Funding Agreement
4M ago
OPT
Opthea to Receive US$35M Commitment and Additional US$50M Funding
PremiumPress Releases
Opthea to Receive US$35M Commitment and Additional US$50M Funding
4M ago
OPT
Opthea Receives A$8.8 million R&D Tax Incentive
PremiumPress Releases
Opthea Receives A$8.8 million R&D Tax Incentive
5M ago
OPT
Opthea to Present at the Jefferies 2023 London Healthcare Conference
PremiumPress Releases
Opthea to Present at the Jefferies 2023 London Healthcare Conference
6M ago
OPT
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
PremiumPress Releases
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
6M ago
OPT
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
PremiumPress Releases
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
6M ago
OPT
Opthea CEO Megan Baldwin to transition out of role, Frederic Guerard to succeed
PremiumThe Fly
Opthea CEO Megan Baldwin to transition out of role, Frederic Guerard to succeed
6M ago
OPT
Opthea Ltd (ADR) trading halted, news pending
PremiumThe FlyOpthea Ltd (ADR) trading halted, news pending
6M ago
OPT
Opthea to Participate at the 2023 Euretina Congress
PremiumPress Releases
Opthea to Participate at the 2023 Euretina Congress
7M ago
OPT
Opthea price target lowered to $12 from $22 at Citi
PremiumThe Fly
Opthea price target lowered to $12 from $22 at Citi
8M ago
OPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >